ClinConnect ClinConnect Logo
Search / Trial NCT06565377

Multimodal Biopsychosocial Teleprehabilitation for Total Knee Arthroplasty

Launched by UNIVERSITAIR ZIEKENHUIS BRUSSEL · Aug 19, 2024

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Total Knee Arthroplasty Knee Replacement Prehabilitation

ClinConnect Summary

This clinical trial is studying a new program called multimodal biopsychosocial teleprehabilitation (BPS-teleprehab) for people who are scheduled to have total knee replacement surgery, also known as total knee arthroplasty (TKA). The goal of this program is to prepare patients better for their surgery by providing information and support before the procedure, helping them to recover more effectively afterward, and improving their overall experience. Researchers want to find out if this program is safe, acceptable, and helpful compared to the usual preoperative advice given to patients.

To be eligible for this trial, participants should be adults over 18 years old who are scheduled for elective knee replacement surgery and can read and understand Dutch. However, individuals who are very active (doing strenuous activities for more than 300 minutes a week), have certain health conditions that could affect their ability to exercise safely, or have cognitive impairments are not eligible. If you join the study, you can expect to receive guidance and support through telehealth (online sessions), which will help you prepare for surgery and rehabilitation. This trial aims to gather important information that could lead to a larger study in the future, potentially improving care for many patients undergoing knee replacement surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • People scheduled for elective primary TKA at one of the participating hospitals;
  • Being over 18 years old;
  • Dutch speaking/reading
  • Exclusion Criteria:
  • Doing activities that make them feel out of breath for 300 minutes or more per week on average;
  • Orthopedic, neurological, cardiovascular or any other condition/comorbidity that leads to an overall contraindication for moderate physical activity;
  • Cognitive impairment (≥11 on 6-item Cognitive Impairment Test and/or unable to understand the study instructions);
  • Presence of uncontrolled inflammatory arthritides (e.g., rheumatoid arthritis, gout);
  • Uncontrolled psychiatric disorders;
  • Active cancer and/or active cancer treatment ((hormonal) maintenance therapy is allowed);
  • People undergoing emergency (non-elective) TKA.

About Universitair Ziekenhuis Brussel

Universitair Ziekenhuis Brussel (UZ Brussel) is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution affiliated with the Vrije Universiteit Brussel, UZ Brussel integrates cutting-edge medical research with high-quality patient care. The hospital's multidisciplinary teams are dedicated to exploring novel therapeutic approaches and contributing to the development of evidence-based treatments, ensuring the highest standards of safety and efficacy in clinical research. With a strong focus on collaboration and knowledge dissemination, UZ Brussel plays a pivotal role in shaping the future of medicine and improving patient outcomes.

Locations

Geel, Antwerpen, Belgium

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Patients applied

0 patients applied

Trial Officials

Eva Huysmans, PhD

Principal Investigator

Vrije Universiteit Brussel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported